News

Chemestmed Joins Estonian HealthTech Innovators in London

24.10.2025

Chemestmed was pleased to take part in a recent delegation of Estonian HealthTech innovators in London.

Chemestmed Partners with FutureNeuro Research Ireland Centre and UCD to Explore METTL3/14 Activators for Epilepsy

 

10.09.2025

Chemestmed is proud to announce a new research collaboration with FutureNeuro, the Research Ireland Centre for Translational Brain Science, and the research team led by Dr. Gary Brennan at University College Dublin.

Accelerating IND Submissions with AI: Chemestmed and Tehistark collaborate on AI platform for IND documentation

10.06.2025

Chemestmed and Tehistark have secured €150,000 funding from the Estonian Business and Innovation Agency to develop and test an AI-powered platform for preparing Investigational New Drug (IND) documentation. The collaboration aims to transform the regulatory submission process using experimental data from Chemestmed’s preclinical programs.

Welcoming New Team Members to Chemestmed

06.06.2025

We are excited to welcome two new members to the Chemestmed team – Baiba Brumele and Juhan Pikamäe – who bring valuable experience and fresh perspectives to our research efforts.

Maarjavälja Career Day 2025

11.03.2025

Last week was packed with exciting events! While Chemestmed was represented at the RNA Leaders Congress in Basel, we also participated in the Maarjavälja Career Day at the University of Tartu on March 5th.

Chemestmed at RNA Leaders Congress Europe

11.03.2025

Poster presentation & great discussions in sunny Basel!

BIO International

03.07.2024